trial · primary record
DB-1303/BNT323
HER2-positive Breast Cancer
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 228 |
| Primary completion | 2028-12 |
| Primary endpoint | Progression Free Survival (PFS) by Blinded Independent Central Review (BICR) assessment per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) |
| Registry ID | NCT06265428 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:45:04.217Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06265428
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.